Lung cancer in pregnancy: Report of nine cases from an international collaborative study

Lung Cancer

Volumn 82, Issue 3, 2013, Pages 499-505

  Boussios, S ^a   Han, S N ^b   Fruscio, R ^c   Halaska, M J ^d   Ottevanger, P B ^e   Peccatori, F A ^f   Koubkova L ^d   Pavlidis, N ^a   Amant, F ^b  

^a UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c SAN GERARDO HOSPITAL   (Italy)

^d CHARLES UNIVERSITY   (Czech Republic)

^e RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^f EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

Chemotherapy; Gestation; Lung cancer; Maternal and fetal outcome; Pregnancy

Indexed keywords

CARBOPLATIN; CISPLATIN; ETOPOSIDE; GEMCITABINE; NADROPARIN; NAVELBINE; PACLITAXEL;

ADRENAL METASTASIS; ADULT; APGAR SCORE; ARTICLE; BACKACHE; BIRTH WEIGHT; BONE METASTASIS; BRAIN METASTASIS; BRONCHOSCOPY; CANCER DIAGNOSIS; CANCER GROWTH; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SIZE; CANCER SURVIVAL; CANCER THERAPY; CESAREAN SECTION; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CURETTAGE; DELIVERY; DETERIORATION; DISEASE SEVERITY; DISSEMINATED INTRAVASCULAR CLOTTING; DYSPHAGIA; DYSPNEA; ERYTHROCYTE TRANSFUSION; FEMALE; FERTILIZATION IN VITRO; FETUS OUTCOME; GAMMA KNIFE RADIOSURGERY; GESTATIONAL AGE; HISTOPATHOLOGY; HOSPITALIZATION; HUMAN; HUMAN TISSUE; INTESTINE RESECTION; LAPAROTOMY; LARGE CELL CARCINOMA; LIVER METASTASIS; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG EMBOLISM; LUNG METASTASIS; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; LYMPH NODE METASTASIS; LYMPHADENOPATHY; MEDIASTINOSCOPY; MEDIASTINUM LYMPH NODE; MITRAL VALVE PROLAPSE; NECROTIZING ENTEROCOLITIS; NEWBORN; NEWBORN INTENSIVE CARE; NUCLEAR MAGNETIC RESONANCE IMAGING; PEDIATRIC SURGERY; PLEURA EFFUSION; PLEURA METASTASIS; PREGNANCY OUTCOME; PREGNANT WOMAN; PREMATURITY; PRIORITY JOURNAL; PUERPERIUM; SEIZURE; SMOKING; SPINAL CORD METASTASIS; SPONTANEOUS ABORTION; SUBCUTANEOUS NODULE; SUPERIOR CAVA VEIN; SYSTEMIC THERAPY; THORAX RADIOGRAPHY; THROMBOCYTE TRANSFUSION; TREATMENT RESPONSE; TUMOR INVASION; ULTRASOUND; WEIGHT REDUCTION; WHOLE BODY MRI;

CHEMOTHERAPY; GESTATION; LUNG CANCER; MATERNAL AND FETAL OUTCOME; PREGNANCY;

ABORTION, SPONTANEOUS; ADENOCARCINOMA; ADULT; COOPERATIVE BEHAVIOR; EUROPE; FEMALE; HUMANS; INTERNATIONAL COOPERATION; LUNG NEOPLASMS; NEOPLASM METASTASIS; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; PREMATURE BIRTH; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 84887617972     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2013.09.002     Document Type: Article

References (43)

1. Pentheroudakis G., Pavlidis N. Cancer and pregnancy: poena magna, not anymore. Eur J Cancer 2006, 42:126-140.
2. Van Calsteren K., Heyns L., De Smet F., Van Eycken L., Gziri M.M., Van Gemert W., et al. Cancer during pregnancy: an analysis of 215 patients emphasizing the obstetrical and the neonatal outcomes. J Clin Oncol 2010, 28:683-689.
3. Peto R., Darby S., Deo H., Silcocks P., Whitley E., Doll R. Smoking, smoking cessation, and lung cancer in the US since 1950: combination of national statistics with two case-control studies. BMJ 2000, 321:323-329.
4. Pisani P., Parkin D.M., Bray F., Ferlay J. Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 1999, 83:18-29.
5. Surbone A., Peccatori F., Pavlidis N. Cancer and pregnancy. Recent results in cancer research 2008, Springer, Berlin.
6. Jackisch C., Louwen F., Schwenkhagen A., Karbowski B., Schmid K.W., Schneider H.P., et al. Lung cancer during pregnancy involving the products of conception and a review of the literature. Arch Gynecol Obstet 2003, 268:69-77.
7. Azim H.A., Peccatori F.A., Pavlidis N. Lung cancer in the pregnant woman: to treat or not to treat, that is the question. Lung Cancer 2008, 67:251-256.
8. Rivas G., Llinás N., Bonilla C., Rubiano J., Cuello J., Arango N. Use of erlotinib throughout pregnancy: a case-report of a patient with metastatic lung adenocarcinoma. Lung Cancer 2012, 77:469-472.
9. Lee C.H., Liam C.K., Pang Y.K., Chua K.T., Lim B.K., Lai N.L. Successful pregnancy with epidermal growth factor receptor tyrosine kinase inhibitor treatment of metastatic lung adenocarcinoma presenting with respiratory failure. Lung Cancer 2011, 74:349-351.
10. Liu L.Y., Zhang W.Z., Guan J., Tong W.C., Cai S.X., Shen X.B., et al. Lung cancer in pregnancy: report of two cases and review of literature. Zhonghua Jie He He Hu Xi Za Zhi 2010, 33:844-848.
11. Sariman N., Levent E., Yener N.A., Orki A., Saygi A. Lung cancer and pregnancy. Lung Cancer 2013, 79:321-323.
12. Thelmo M.C., Shen E.P., Shertukde S. Metastatic pulmonary adenocarcinoma to placenta and pleural fluid: clinicopathologic findings. Fetal Pediatr Pathol 2010, 29:45-56.
13. Hayama M., Chida M., Tamura M., Kobayashi S., Oyaizu T., Honma K. Unexpected rapid growth of estrogen receptor positive lung cancer during pregnancy. Ann Thorac Cardiovasc Surg 2013, [Epub ahead of print].
14. Pentheroudakis G., Pavlidis N. Gastrointestinal, urologic and lung malignancies during pregnancy. Recent Results Cancer Res 2008, 178:137-164.
15. Baysinger C.L. Imaging during pregnancy. Anesth Analg 2010, 110:863-867.
16. Patel S.J., Reede D.L., Katz D.S., Subramaniam R., Amorosa J.K. Imaging the pregnant patient for nonobstetric conditions: algorithms and radiation dose considerations. Radiographics 2007, 27:1705-1722.
17. Abdel-Hady el-S., Hemida R.A., Gamal A., El-Zafarany M., Toson E., El-Bayoumi M.A. Cancer during pregnancy: perinatal outcome after in utero exposure to chemotherapy. Arch Gynecol Obstet 2012, 286:283-286.
18. Cardonick E., Iacobucci A. Use of chemotherapy during human pregnancy. Lancet Oncol 2004, 5:283-291.
19. Pentheroudakis G., Orecchia R., Hoekstra H.J., Pavlidis N. Cancer, fertility and pregnancy: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010, 21:266-273.
20. Amant F., Van Calsteren K., Halaska M.J., Gziri M.M., Hui W., Lagae L., et al. Long term cognitive and cardiac outcomes after prenatal exposure to chemotherapy in children aged 18 months or older: an observational study. Lancet Oncol 2012, 13:256-264.
21. Tabata T., Nishiura K., Tanida K., Kondo E., Okugawa T., Sagawa N. Carboplatin chemotherapy in a pregnant patient with undifferentiated ovarian carcinoma: case report and review of the literature. Int J Gynecol Cancer 2008, 18:181-184.
22. Robova H., Rob L., Hrehorcak M., Zoban P., Prusa R. Endodermal sinus tumor diagnosed in pregnancy: a case report. Int J Gynecol Cancer 2007, 17:914-916.
23. Mir O., Berveiller P., Ropert S., Goffinet F., Goldwasser F. Use of platinum derivatives during pregnancy. Cancer 2008, 113:3069-3074.
24. Zemlickis D., Klein J., Moselhy G., Koren G. Cisplatin protein binding in pregnancy and the neonatal period. Med Pediatr Oncol 1994, 23:476-479.
25. Wiebe V.J., Sipila P.E. Pharmacology of antineoplastic agents in pregnancy. Crit Rev Oncol Hematol 1994, 16:75-112.
26. Van Calsteren K., Verbesselt R., Beijnen J., et al. Transplacental transfer of paclitaxel, docetaxel, carboplatin and trastuzumab in a baboon model. Int J Gynecol Cancer 2010, 20:1456-1464.
27. Koshiba H., Hosokawa K., Mori T., Kubo A., Watanabe A., Honjo H. Intravenous paclitaxel is specifically retained in human gynecologic carcinoma tissues in vivo. Int J Gynecol Cancer 2009, 19:484-488.
28. Mir O., Berveiller P., Ropert S., Goffinet F., Pons G., Treluyer J.M., et al. Emerging therapeutic options for breast cancer chemotherapy during pregnancy. Ann Oncol 2008, 19:607-613.
29. Garcia-Gonzalez J., Cueva J., Lamas M.J., Curiel T., Graña B., López-López R. Paclitaxel and cisplatin in the treatment of metastatic non-small-cell lung cancer during pregnancy. Clin Transl Oncol 2008, 10:375-376.
30. Mir O., Berveiller P., Goffinet F., et al. Taxanes for breast cancer during pregnancy: a systematic review. Ann Oncol 2010, 21:425-426.
31. Amant F., Han S.N., Gziri M.M., Dekrem J., Van Calsteren K. Chemotherapy during pregnancy. Curr Opin Oncol 2012, 24:580-586.
32. Van Calsteren K., Verbesselt R., Ottevanger N., Halaska M., Heyns L., Van Bree R., et al. Pharmacokinetics of chemotherapeutic agents in pregnancy: a preclinical and clinical study. Acta Obstet Gynecol Scand 2010, 89:1338-1345.
33. Zambelli A., Prada G.A., Fregoni V., et al. Erlotinib administration for advanced non-small cell lung cancer during the first 2 months of unrecognized pregnancy. Lung Cancer 2008, 60:455-457.
34. Azim H.A, Azim H., Peccatori F.A. Treatment of cancer during pregnancy with monoclonal antibodies: a real challenge. Expert Rev Clin Immunol 2010, 6:821-826.
35. Demir R., Seval Y., Huppertz B. Vasculogenesis and angiogenesis in the early human placenta. Acta Histochem 2007, 109:257-265.
36. Pauli S.A., Tang H., Wang J., et al. The vascular endothelial growth factor (VEGF)/VEGF receptor 2 pathway is critical for blood vessel survival in corpora lutea of pregnancy in the rodent. Endocrinology 2005, 146:1301-1311.
37. Ferrara N., Carver-Moore K., Chen H., et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 1996, 380:439-442.
38. Patyna S., Haznedar J., Morris D., et al. Evaluation of the safety and pharmacokinetics of the multi-targeted receptor tyrosine kinase inhibitor sunitinib during embryo-fetal development in rats and rabbits. Birth Defects Res B: Dev Reprod Toxicol 2009, 86:204-213.
39. Stephens T.D., Fillmore B.J. Hypothesis: thalidomide embryopathy-proposed mechanism of action. Teratology 2000, 61:189-195.
40. Doll R., Wakeford R. Risk of childhood cancer from fetal irradiation. Br J Radiol 1997, 70:130-139.
41. Rothman L.A., Cohen C.J., Astarloa J. Placental and fetal involvement by maternal malignancy: a report of rectal carcinoma and review of the literature. Am J Obstet Gynecol 1973, 116:1023-1034.
42. Alexander A., Samlowski W.E., Grossman D., Bruggers C.S., Harris R.M., Zone J.J., et al. Metastatic melanoma in pregnancy: risk of transplacental metastases in the infant. J Clin Oncol 2003, 21:2179-2186.
43. Pavlidis N., Pentheroudakis G. Metastatic involvement of placenta and foetus in pregnant women with cancer. Recent Results Cancer Res 2008, 178:183-194.